32. Chihana, M., Huerga, H., Van Cutsem, G., Ellman, T., Goemaere, E., et al., 2019. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi). Global Health Action, 12(1), p.1679472.
33. Ehrenkranz, P., Baptiste, S., Bygrave, H., Ellman, T., Doi, N., Grimsrud, A., et al., 2019. The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings. PLOS Medicine, 16(5), p.e1002820.
34. Gill, N., Van den Bergh, R., Wut Yee Kyaw, K., Laxmeshwar, C., Das, M., et al., 2019. Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India. PLOS ONE, 14(11), p.e0225631.
35. Govender, N., Meintjes, G., Mangena, P., Nel, J., Potgieter, S., et al., 2019. Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. Southern African Journal of HIV Medicine, 20(1).
36. Hacking, D., Mgengwana-Mbakaza, Z., Cassidy, T., Runeyi, P., Duran, L., et al., 2019. Peer Mentorship via Mobile Phones for Newly Diagnosed HIV-Positive Youths in Clinic Care in Khayelitsha, South Africa: Mixed Methods Study. Journal of Medical Internet Research, 21(12), p.e14012.
37. Holmes, C., Rabkin, M., Ford, N., Preko, P., Rosen, S., et al., 2019. Tailored HIV programmes and universal health coverage. Bulletin of the World Health Organization, 98(2), pp.87-94.
38. Loarec, A., Carnimeo, V., Molfino, L., Kizito, W., Muyindike, W., et al., 2019. Extremely low hepatitis C prevalence among HIV co-infected individuals in four countries in sub-Saharan Africa. AIDS, 33(2), pp.353-355.
39. Moore, H., Metcalf, C., Cassidy, T., Hacking, D., Shroufi, A., et al., 2019. Investigating the addition of oral HIV self-tests among populations with high testing coverage – Do they add value? Lessons from a study in Khayelitsha, South Africa. PLOS ONE, 14(5), p.e0215454.
40. Nyagadza, B., Kudya, N., Mbofana, E., Masaka, S., Garone, D., et al., 2019. Scaling up HIV viral load monitoring in Manicaland, Zimbabwe: challenges and opportunities from the field. Public Health Action, 9(4), pp.177-181.
41. Pulido Tarquino, I., Venables, E., de Amaral Fidelis, J., Giuliani, R. and Decroo, T., 2019. “I take my pills every day, but then it goes up, goes down. I don’t know what’s going on”: Perceptions of HIV virological failure in a rural context in Mozambique. A qualitative research study. PLOS ONE, 14(6), p.e0218364.
42. Rice, B., Boulle, A., Schwarcz, S., Shroufi, A., Rutherford, G., et al., 2019. The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance. JMIR Public Health and Surveillance, 5(1), p.e11136.
43. Sacks, J., Fong, Y., Gonzalez, M., Andreotti, M., Baliga, S., et al., 2019. Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. AIDS, 33(12), pp.1881-1889.
44. Sharp, J., Wilkinson, L., Cox, V., Cragg, C., van Cutsem, G., et al., 2019. Outcomes of patients enrolled in an antiretroviral adherence club with recent viral suppression after experiencing elevated viral loads. Southern African Journal of HIV Medicine, 20(1).
45. Shroufi, A., Van Cutsem, G., Cambiano, V., Bansi-Matharu, L., Duncan, K., et al., 2019. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa. AIDS, 33(10), pp.1635-1644.
46. Venables, E., Casteels, I., Manziasi Sumbi, E. and Goemaere, E., 2019. “Even if she’s really sick at home, she will pretend that everything is fine.”: Delays in seeking care and treatment for advanced HIV disease in Kinshasa, Democratic Republic of Congo. PLOS ONE, 14(2), p.e0211619.
47. Venables, E., Ndlovu, Z., Munyaradzi, D., Martínez-Pérez, G., Mbofana, E., et al., 2019. Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study. PLOS ONE, 14(4), p.e0215236.
48. Venables, E., Towriss, C., Rini, Z., Nxiba, X., Cassidy, T., et al., 2019. Patient experiences of ART adherence clubs in Khayelitsha and Gugulethu, Cape Town, South Africa: A qualitative study. PLOS ONE, 14(6), p.e0218340.
49. Wilkinson, L., Grimsrud, A., Cassidy, T., Orrell, C., Voget, J., et al., 2019. A cluster randomized controlled trial of extending ART refill intervals to six-monthly for anti-retroviral adherence clubs. BMC Infectious Diseases, 19(1).